<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>FLAVOXATE HYDROCHLORIDE- flavoxate hydrochlorideÂ tabletÂ </strong><br>Golden State Medical Supply, Inc.<br></p></div>
<h1>Flavoxate Hydrochloride Tablets 100 mg, Film-Coated<br>Rx only</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_f2dca30d-58eb-4b21-9484-5bed8e22c44d"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Flavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.</p>
<p>Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4<span class="Underline">H</span>-1-benzopyran-8-carboxylate hydrochloride. The empirical formula of flavoxate hydrochloride is C<span class="Sub">24</span>H<span class="Sub">25</span>NO<span class="Sub">4</span>â€¢HCl. The molecular weight is 427.94. The structural formula appears below.</p>
<div class="Figure"><img alt="Chemical Structure - Flavoxate" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=22a99f74-2718-48b3-b686-caf102d3071c&amp;name=22a99f74-2718-48b3-b686-caf102d3071c-01.jpg"></div>
<p>Each tablet for oral administration contains 100 mg flavoxate hydrochloride. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch, dibasic calcium phosphate dihydrate, hypromellose, polydextrose, magnesium stearate, titanium dioxide and triacetin.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_bbba6593-4e23-4362-8b55-5d6cfb5d0c13"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Flavoxate hydrochloride counteracts smooth <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">muscle spasm</span> of the urinary tract and exerts its effect directly on the muscle.</p>
<p>In a single study of 11 normal male subjects, the time to onset of action was 55 minutes. The peak effect was observed at 112 minutes. 57% of the flavoxate hydrochloride was excreted in the urine within 24 hours.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_25cf5cb1-dc0b-45ee-950d-b7c595f0a414"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Flavoxate hydrochloride tablets are indicated for symptomatic relief of <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">dysuria</span>, urgency, <span class="product-label-link" type="condition" conceptid="40304526" conceptname="Nocturia">nocturia</span>, <span class="product-label-link" type="condition" conceptid="4012498" conceptname="Suprapubic pain">suprapubic pain</span>, frequency and <span class="product-label-link" type="condition" conceptid="444035" conceptname="Incontinence">incontinence</span> as may occur in <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>, <span class="product-label-link" type="condition" conceptid="194997" conceptname="Prostatitis">prostatitis</span>, <span class="product-label-link" type="condition" conceptid="195862" conceptname="Urethritis">urethritis</span>, urethrocystitis/urethrotrigonitis. Flavoxate hydrochloride tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of <span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">urinary tract infections</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_d92c50d1-2d34-47c0-a154-5c8720d7240e"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Flavoxate hydrochloride is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>, achalasia, <span class="product-label-link" type="condition" conceptid="192671" conceptname="Gastrointestinal hemorrhage">gastrointestinal hemorrhage</span> and obstructive uropathies of the lower urinary tract.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_94975bd7-90f9-4686-9a4d-47860732878f"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Flavoxate hydrochloride should be given cautiously in patients with suspected <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_32b3ac98-b063-4dba-b2f7-7636695ab988"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_623bfe69-5cea-417b-9ff6-f2570e4e0dc3"></a><a name="section-6.1"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be informed that if <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> and <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span> occur, they should not operate a motor vehicle or machinery or participate in activities where alertness is required.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_b719f62c-5c73-4a78-b5d5-cee2a14ab320"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Mutagenicity studies and long-term studies in animals to determine the carcinogenic potential of flavoxate hydrochloride have not been performed.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_e565b98a-a8e4-4810-838a-99eb5e3c912f"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_73fe926f-2d15-44eb-ae18-7f2c83195a54"></a><a name="section-6.3.1"></a><p></p>
<h3><span class="Italics"><span class="Bold">Teratogenic Effects-Pregnancy Category B.</span></span></h3>
<p class="First">Reproduction studies have been performed in rats and rabbits at doses up to 34 times the human dose and revealed no evidence of impaired fertility or harm to the fetus due to flavoxate hydrochloride. There are, however, no well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_efb61ee1-4dd5-4ad7-a31e-aa82ec8c823a"></a><a name="section-6.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when flavoxate hydrochloride is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_3c339a20-26eb-49d3-af96-1434065c6848"></a><a name="section-6.5"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in children below the age of 12 years have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_fd6d7095-16bb-4ca4-b0bc-60d3ec9d5933"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.</p>
<p><span class="Bold">Gastrointestinal: </span><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>.</p>
<p><span class="Bold">CNS: </span><span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">Vertigo</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, especially in the elderly, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>.</p>
<p><span class="Bold">Hematologic: </span><span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">Leukopenia</span> (one case which was reversible upon discontinuation of the drug).</p>
<p><span class="Bold">Cardiovascular: </span><span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">Tachycardia</span> and <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>.</p>
<p><span class="Bold">Allergic</span>: <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span> and other dermatoses, <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> and <span class="product-label-link" type="condition" conceptid="4260205" conceptname="Hyperpyrexia">hyperpyrexia</span>.</p>
<p><span class="Bold">Ophthalmic: </span>Increased ocular <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, disturbance in eye accommodation.</p>
<p><span class="Bold">Renal: </span><span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">Dysuria</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_760814af-9bc1-4936-8a99-7a9b33524aba"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The oral LD<span class="Sub">50</span> for flavoxate hydrochloride in rats is 4273 mg/kg. The oral LD<span class="Sub">50</span> for flavoxate hydrochloride in mice is 1837 mg/kg.</p>
<p>It is not known whether flavoxate hydrochloride is dialyzable.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_7da0d6e3-39da-45c5-a294-f04c052c2fb4"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d2f7095f-1990-4ad5-a015-ef338abc681f"></a><a name="section-9.1"></a><p></p>
<h2>Adults and children over 12 years of age</h2>
<p class="First">One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_10dfabf1-2d02-4cad-b573-2a55e9fbb5fe"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Flavoxate hydrochloride 100 mg tablets are available as white, round biconvex, film-coated tablets, debossed â€œ<span class="Bold">Ð„ 58</span>â€? on one side and plain on the other side, and are available in bottles of 100 <span class="Bold">(NDC 60429-290-01)</span>.</p>
<p>Store at 20Â° - 25Â°C (68Â° - 77Â°F) [see USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container.</p>
<p>Manufactured by: <span class="Bold">Epic Pharma, LLC</span> Laurelton, NY 11413</p>
<p>Marketed/Packaged by: <span class="Bold">GSMS Inc.</span> Camarillo, CA 93012</p>
<p> Â </p>
<p><span class="Bold">Made in USA</span></p>
<p>Issued 01/11</p>
<p>MF058IS01/11</p>
<p>OE1140</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_7fd8a67e-6e43-4830-9bbb-77f93f22e954"></a><a name="section-11"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure"><img alt="Label Graphic - 100 mg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=22a99f74-2718-48b3-b686-caf102d3071c&amp;name=22a99f74-2718-48b3-b686-caf102d3071c-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>FLAVOXATE HYDROCHLORIDEÂ 		
					</strong><br><span class="contentTableReg">flavoxate hydrochloride tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:60429-290(NDC:42806-058)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>FLAVOXATE HYDROCHLORIDE</strong> (FLAVOXATE) </td>
<td class="formItem">FLAVOXATE</td>
<td class="formItem">100Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>DIBASIC CALCIUM PHOSPHATE DIHYDRATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYDEXTROSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TRIACETIN</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">11mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">E58</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:60429-290-01</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA076835</td>
<td class="formItem">02/21/2011</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Golden State Medical Supply, Inc.
							(603184490)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Golden State Medical Supply, Inc.</td>
<td class="formItem"></td>
<td class="formItem">603184490</td>
<td class="formItem">REPACK(60429-290), RELABEL(60429-290)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>22a99f74-2718-48b3-b686-caf102d3071c</div>
<div>Set id: 22a99f74-2718-48b3-b686-caf102d3071c</div>
<div>Version: 1</div>
<div>Effective Time: 20110701</div>
</div>
</div>Â <div class="DistributorName">Golden State Medical Supply, Inc.</div></p>
</body></html>
